{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:49:41Z","timestamp":1767134981419,"version":"build-2238731810"},"update-to":[{"DOI":"10.1002\/14651858.cd009300","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2014,1,15]],"date-time":"2014-01-15T00:00:00Z","timestamp":1389744000000}}],"reference-count":51,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd009300.pub2","type":"journal-article","created":{"date-parts":[[2014,1,15]],"date-time":"2014-01-15T16:59:03Z","timestamp":1389805143000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Complement inhibitors for age-related macular degeneration"],"prefix":"10.1002","author":[{"given":"Michael A","family":"Williams","sequence":"first","affiliation":[{"name":"Royal Victoria Hospital; Medical Ophthalmology, Eye and Ear Clinic; Grosvenor Road Belfast Northern Ireland UK BT12 6BA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gareth J","family":"McKay","sequence":"additional","affiliation":[{"name":"Queen's University Belfast; Centre for Public Health; Belfast Northern Ireland UK BT12 6BA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Usha","family":"Chakravarthy","sequence":"additional","affiliation":[{"name":"Queen's University Belfast; Centre for Vision and Vascular Science; Belfast Northern Ireland UK BT12 6BA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,1,15]]},"reference":[{"key":"10.1002\/14651858.CD009300.pub2-BIB0001|cit1","unstructured":"NCT00935883 Eculizumab for the treatment of non-exudative age-related macular degeneration: an exploratory study to evaluate the effects of C5 inhibition on drusen and geographic atrophy clinicaltrials.gov\/show\/NCT00935883"},{"key":"10.1002\/14651858.CD009300.pub2-BIB0002|cit2","unstructured":"NCT00950638 A phase I study of ARC1905 (anti-C5 aptamer) in subjects with dry age-related macular degeneration clinicaltrials.gov\/show\/Nct00950638"},{"key":"10.1002\/14651858.CD009300.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1038\/nrd3063","article-title":"Deal watch: Alcon licenses complement pathway inhibitor for macular degeneration","volume":"8","author":"Anonymous","year":"2009","journal-title":"Nature Reviews Drug Discovery"},{"issue":"10","key":"10.1002\/14651858.CD009300.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1001\/archopht.119.10.1417","article-title":"A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8","volume":"119","author":"Age-Related Eye Disease Study Research Group","year":"2001","journal-title":"Archives of Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD009300.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1001\/archopht.124.4.529","article-title":"Prevalence of age-related maculopathy in older Europeans: the European Eye Study (EUREYE)","volume":"124","author":"Augood","year":"2006","journal-title":"Archives of Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD009300.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"491","DOI":"10.4049\/jimmunol.174.1.491","article-title":"Role of complement and complement membrane attack complex in laser-induced choroidal neovascularization","volume":"174","author":"Bora","year":"2005","journal-title":"Journal of Immunology"},{"issue":"3","key":"10.1002\/14651858.CD009300.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1467-7652.2010.00552.x","article-title":"Production of biologically active recombinant human factor H in Physcomitrella","volume":"9","author":"B\u00fcttner-Mainik","year":"2011","journal-title":"Plant Biotechnology Journal"},{"key":"10.1002\/14651858.CD009300.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1471-2415-10-31","article-title":"Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis","volume":"10","author":"Chakravarthy","year":"2010","journal-title":"BMC Ophthalmology"},{"issue":"23","key":"10.1002\/14651858.CD009300.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"14682","DOI":"10.1073\/pnas.222551899","article-title":"Drusen proteome analysis: an approach to the etiology of age-related macular degeneration","volume":"99","author":"Crabb","year":"2002","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1002\/14651858.CD009300.pub2-BIB0010|cit10","unstructured":"Deeks JJ Higgins JPT Altman DG (editors) Chapter 9: Analysing data and undertaking meta-analyses In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011"},{"issue":"3","key":"10.1002\/14651858.CD009300.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1001\/jama.296.3.301","article-title":"Complement factor H polymorphism, complement activators, and risk of age-related macular degeneration","volume":"296","author":"Despriet","year":"2006","journal-title":"JAMA"},{"issue":"5720","key":"10.1002\/14651858.CD009300.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1126\/science.1110189","article-title":"Complement factor H polymorphism and age-related macular degeneration","volume":"308","author":"Edwards","year":"2005","journal-title":"Science"},{"issue":"3","key":"10.1002\/14651858.CD009300.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.ophtha.2003.07.012","article-title":"Age-related macular degeneration causing visual impairment in people 75 years or older in Britain: an add-on study to the Medical Research Council Trial of Assessment and Management of Older People in the Community","volume":"111","author":"Evans","year":"2004","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD009300.pub2-BIB0014|cit14","first-page":"130","article-title":"How to identify randomized controlled trials in MEDLINE: ten years on","volume":"94","author":"Glanville","year":"2006","journal-title":"Journal of the Medical Library Association"},{"issue":"6","key":"10.1002\/14651858.CD009300.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S1350-9462(01)00010-6","article-title":"An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration","volume":"20","author":"Hageman","year":"2001","journal-title":"Progress in Retinal and Eye Research"},{"issue":"20","key":"10.1002\/14651858.CD009300.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"7227","DOI":"10.1073\/pnas.0501536102","article-title":"A common haplotype in the complement regulatory gene factor H (HF1\/CFH) predisposes individuals to age-related macular degeneration","volume":"102","author":"Hageman","year":"2005","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"5720","key":"10.1002\/14651858.CD009300.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1126\/science.1110359","article-title":"Complement factor H variant increases the risk of age-related macular degeneration","volume":"308","author":"Haines","year":"2005","journal-title":"Science"},{"issue":"43","key":"10.1002\/14651858.CD009300.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"16725","DOI":"10.1073\/pnas.0708151104","article-title":"Bringing the genetics of macular degeneration into focus","volume":"104","author":"Haines","year":"2007","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1-2","key":"10.1002\/14651858.CD009300.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jneuroim.2006.11.017","article-title":"Inflammatory processes in Alzheimer's disease","volume":"184","author":"Heneka","year":"2007","journal-title":"Journal of Neuroimmunology"},{"issue":"7414","key":"10.1002\/14651858.CD009300.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD009300.pub2-BIB0021|cit21","unstructured":"Higgins JPT Altman DG Sterne JAC (editors) Chapter 8: Assessing risk of bias in included studies In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011"},{"issue":"5","key":"10.1002\/14651858.CD009300.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.ophtha.2006.11.013","article-title":"Early features of AMD","volume":"114","author":"Hogg","year":"2007","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD009300.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00417-010-1568-6","article-title":"The significance of the complement system for the pathogenesis of age-related macular degeneration - current evidence and translation into clinical application","volume":"249","author":"Issa","year":"2011","journal-title":"Graefe's Archive for Clinical and Experimental Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD009300.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1006\/exer.1999.0798","article-title":"A potential role for immune complex pathogenesis in drusen formation","volume":"70","author":"Johnson","year":"2000","journal-title":"Experimental Eye Research"},{"issue":"18","key":"10.1002\/14651858.CD009300.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"11830","DOI":"10.1073\/pnas.192203399","article-title":"The Alzheimer's A beta -peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration","volume":"99","author":"Johnson","year":"2002","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"2","key":"10.1002\/14651858.CD009300.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.imbio.2011.07.019","article-title":"Age-related macular degeneration and the complement system","volume":"217","author":"Khandhadia","year":"2012","journal-title":"Immunobiology"},{"key":"10.1002\/14651858.CD009300.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1136\/bmj.c365","article-title":"The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews","volume":"340","author":"Kirkham","year":"2010","journal-title":"BMJ"},{"issue":"5720","key":"10.1002\/14651858.CD009300.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1126\/science.1109557","article-title":"Complement factor H polymorphism in age-related macular degeneration","volume":"308","author":"Klein","year":"2005","journal-title":"Science"},{"issue":"3","key":"10.1002\/14651858.CD009300.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2353\/ajpath.2007.070166","article-title":"The role of complement in inflammatory diseases from behind the scenes into the spotlight","volume":"171","author":"Markiewski","year":"2007","journal-title":"American Journal of Pathology"},{"key":"10.1002\/14651858.CD009300.pub2-BIB0030|cit30","unstructured":"Safety of intravitreal POT-4 therapy for patients with neovascular age-related macular degeneration ClinicalTrials.gov\/show\/NCT00473928"},{"key":"10.1002\/14651858.CD009300.pub2-BIB0031|cit31","unstructured":"ARC1905 (ANTI-C5 APTAMER) given either in combination therapy with Lucentis\u00ae 0.5 mg\/eye in subjects with neovascular age-related macular degeneration ClinicalTrials.gov\/show\/NCT00709527"},{"issue":"3","key":"10.1002\/14651858.CD009300.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1136\/bjo.87.3.312","article-title":"How big is the burden of visual loss caused by age related macular degeneration in the United Kingdom?","volume":"87","author":"Owen","year":"2003","journal-title":"British Journal of Ophthalmology"},{"issue":"6","key":"10.1002\/14651858.CD009300.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/sj.eye.6702844","article-title":"Age-related macular degeneration: a perspective on genetic studies","volume":"22","author":"Patel","year":"2008","journal-title":"Eye"},{"key":"10.1002\/14651858.CD009300.pub2-BIB0034|cit34","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2012"},{"issue":"11","key":"10.1002\/14651858.CD009300.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1038\/nbt1342","article-title":"Complement-targeted therapeutics","volume":"25","author":"Ricklin","year":"2007","journal-title":"Nature Biotechnology"},{"key":"10.1002\/14651858.CD009300.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1136\/bmj.d549","article-title":"Interpretation of random effects meta-analyses","volume":"342","author":"Riley","year":"2011","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD009300.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.molimm.2004.02.005","article-title":"The human complement factor H: functional roles, genetic variations and disease associations","volume":"41","author":"Rodriguez de Cordoba","year":"2004","journal-title":"Molecular Immunology"},{"key":"10.1002\/14651858.CD009300.pub2-BIB0038|cit38","doi-asserted-by":"crossref","unstructured":"Schwartz SG Brantley MA Jr Pharmacogenetics and age-related macular degeneration Journal of Ophthalmology 2011 Article ID 252549 10.1155\/2011\/252549","DOI":"10.1155\/2011\/252549"},{"issue":"2","key":"10.1002\/14651858.CD009300.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0002-9394(14)71036-0","article-title":"Familial aggregation of age-related maculopathy","volume":"124","author":"Seddon","year":"1997","journal-title":"American Journal of Ophthalmology"},{"issue":"8","key":"10.1002\/14651858.CD009300.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/sj.eye.6702176","article-title":"The complement system and age-related macular degeneration","volume":"20","author":"Sivaprasad","year":"2006","journal-title":"Eye"},{"key":"10.1002\/14651858.CD009300.pub2-BIB0041|cit41","unstructured":"Sterne JAC Egger M Moher D (editors) Chapter 10: Addressing reporting biases In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011"},{"issue":"5","key":"10.1002\/14651858.CD009300.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/j.1747-0285.2012.01324.x","article-title":"Molecular dynamics in drug design: new generations of compstatin analogs","volume":"79","author":"Tamamis","year":"2012","journal-title":"Chemical Biology and Drug Design"},{"issue":"9","key":"10.1002\/14651858.CD009300.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/sj.eye.6701978","article-title":"Smoking and age-related macular degeneration: a review of association","volume":"19","author":"Thornton","year":"2005","journal-title":"Eye"},{"issue":"1","key":"10.1002\/14651858.CD009300.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1442-9071.2011.02581.x","article-title":"Therapeutic targeting of the complement system in age-related macular degeneration: a review","volume":"40","author":"Troutbeck","year":"2012","journal-title":"Clinical and Experimental Ophthalmology"},{"key":"10.1002\/14651858.CD009300.pub2-BIB0045|cit45","unstructured":"www.alexionpharm.com\/"},{"key":"10.1002\/14651858.CD009300.pub2-BIB0046|cit46","unstructured":"www.archemix.com\/website\/index.php"},{"key":"10.1002\/14651858.CD009300.pub2-BIB0047|cit47","unstructured":"UPstart at the University of Pennsylvania www.ctt.upenn.edu\/upstart.html"},{"key":"10.1002\/14651858.CD009300.pub2-BIB0048|cit48","unstructured":"www.jerini.com\/cms\/en\/home.php"},{"key":"10.1002\/14651858.CD009300.pub2-BIB0049|cit49","unstructured":"www.ophthotech.com\/"},{"key":"10.1002\/14651858.CD009300.pub2-BIB0050|cit50","unstructured":"www.potentiapharma.com\/about\/news.htm"},{"issue":"9","key":"10.1002\/14651858.CD009300.pub2-BIB0051|cit51","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009300","article-title":"Complement inhibitors for age-related macular degeneration","author":"Williams","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"}],"updated-by":[{"DOI":"10.1002\/14651858.cd009300.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T00:00:00Z","timestamp":1686700800000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD009300.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T18:31:08Z","timestamp":1628533868000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD009300.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Eyes and Vision Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,1,15]]},"references-count":51,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd009300.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,15]]}}}